V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006538 | 310007501 | 1.59 | 55.8 | Curative (C) | 2017-11-13 | 2018-05-02 | Bevacizumab 15mg/kg | 02 | N | 310007302 | BEVACIZUMAB |
| 310006539 | 310003707 | 1.76 | 95 | Palliative (P) | 2016-09-16 | 2016-09-26 | CARBOPLATIN + GEMCITABINE | N | null | 310007307 | GEMCARBO |
| 310006540 | 310007502 | null | null | Curative (C) | 2015-05-18 | 2015-05-21 | EW EuroEwing 2012 Arm B VDC | 2 | null | 310007311 | TRIAL |
| 310006541 | 310007503 | 1.66 | 65.3 | Neo-adjuvant (N) | 2014-11-26 | 2014-12-18 | CHOP - 21 days | N | N | 310007311 | CHOP |
| 310006542 | 310003714 | 1.56 | 83 | null | null | 2016-03-02 | Bevacizumab 15mg/kg | 02 | N | 310007322 | BEVACIZUMAB |
| 310006543 | 310003715 | null | 52 | Palliative (P) | 2016-04-25 | 2016-05-06 | Liposomal Doxorubicin (Caelyx) | null | N | 310007322 | LIPOSOMAL DOXORUBICIN |
| 310006544 | 310003715 | 1.72 | 93 | Disease modification (D) | 2014-12-01 | 2014-12-01 | CHEMO-T TRIAL | Y | N | 310007322 | TRIAL |
| 310006545 | 310011698 | 1.79 | 78.7 | Curative (C) | 2016-07-10 | 2016-12-12 | CHOP | 2 | N | 310007333 | CHOP |
| 310006546 | 310011698 | 1.88 | 73 | Neo-adjuvant (N) | 2014-03-06 | 2014-03-28 | Bevacizumab 7.5mg/kg | N | N | 310007333 | BEVACIZUMAB |
| 310006547 | 310011884 | 1.63 | null | Curative (C) | 2013-06-27 | 2013-06-28 | GemCarbo Days 1+8 | N | null | 310007339 | GEMCARBO |
| 310006548 | 310011947 | 1.76 | 86.2 | null | 2016-08-28 | 2016-09-04 | GemCarbo Days 1+8 | N | N | 310007341 | GEMCARBO |
| 310006549 | 310003716 | 1.55 | 64 | Palliative (P) | 2013-04-14 | 2013-06-23 | Bevacizumab 7.5mg/kg | 02 | N | 310007355 | BEVACIZUMAB |
| 310006550 | 310003717 | 1.61 | 70 | null | 2016-12-21 | 2016-12-24 | GemCarbo Days 1+8 | 02 | N | 310007357 | GEMCARBO |
| 310006551 | 310003718 | 1.76 | 60.5 | Curative (C) | null | 2014-10-02 | CHOP - 21 days | 02 | N | 310007357 | CHOP |
| 310006552 | 310007509 | 1.56 | 63.7 | Disease modification (D) | 2017-11-09 | 2017-11-20 | Trial Unspecified | null | N | 310007362 | TRIAL |
| 310006553 | 310003720 | 1.75 | 66.3 | Unknown (U) | 2015-02-11 | 2015-02-18 | GemCarbo Days 1+8 | N | N | 310007366 | GEMCARBO |
| 310006554 | 310007510 | 1.7 | 76 | null | 2015-12-21 | 2016-01-11 | Trial Unspecified | 01 | N | 310007366 | TRIAL |
| 310006555 | 310003723 | 1.64 | 76.5 | Palliative (P) | 2017-05-05 | 2017-05-13 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310007370 | LIPOSOMAL DOXORUBICIN |
| 310006556 | 310007512 | 1.75 | 74.9 | null | 2015-03-09 | 2016-03-31 | GEMCARBO | 2 | N | 310007371 | GEMCARBO |
| 310006557 | 310003727 | 1.57 | null | Curative (C) | 2016-10-02 | 2016-10-12 | CHOP | N | N | 310007371 | CHOP |
| 310006558 | 310003727 | 1.66 | 58.5 | Palliative (P) | 2017-02-05 | 2018-04-30 | GEMCARBO | N | N | 310007371 | GEMCARBO |
| 310006559 | 310007514 | 1.69 | 65.2 | Curative (C) | 2017-04-17 | 2017-08-28 | CHOP - 21 days | 2 | N | 310007383 | CHOP |
| 310006560 | 310007514 | 1.72 | 78 | Disease modification (D) | 2014-02-24 | 2014-02-24 | CHOP | null | N | 310007383 | CHOP |
| 310006561 | 310003729 | 1.84 | 54.2 | Palliative (P) | null | 2016-07-24 | CHOP - 21 days | 2 | N | 310007387 | CHOP |
| 310006562 | 310003731 | 1.78 | 75.65 | Adjuvant (A) | 2017-08-17 | 2017-09-14 | CHOP - 21 days | 02 | N | 310007389 | CHOP |
| 310006563 | 310003733 | 1.84 | 71.4 | Adjuvant (A) | 2016-03-10 | 2016-03-16 | GemCarbo Days 1+8 | 2 | N | 310007391 | GEMCARBO |
| 310006564 | 310009506 | 1.75 | 82.4 | null | 2013-06-21 | 2013-06-28 | CHOP - 21 days | 2 | N | 310007408 | CHOP |
| 310006565 | 310003734 | 1.75 | 80 | Palliative (P) | null | 2015-01-24 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 310007411 | LIPOSOMAL DOXORUBICIN |
| 310006566 | 310003736 | 1.55 | 62.7 | Palliative (P) | null | 2017-11-03 | CHOP - 21 days | 02 | N | 310007411 | CHOP |
| 310006567 | 310003737 | 1.62 | 57 | Not known (9) | 2016-08-21 | 2016-08-21 | Trial Unspecified | N | N | 310007415 | TRIAL |
| 310006568 | 310010568 | 1.66 | 61 | Palliative (P) | 2014-04-08 | 2014-05-01 | GEMCARBO | 02 | N | 310007425 | GEMCARBO |
| 310006569 | 310010568 | 1.59 | 89.5 | Curative (C) | 2015-08-28 | 2015-08-28 | Trial Unspecified | 02 | N | 310007425 | TRIAL |
| 310006570 | 310010568 | 1.73 | 59.8 | Palliative (P) | 2015-05-26 | 2015-06-04 | GemCarbo Days 1+8 | N | N | 310007425 | GEMCARBO |
| 310006571 | 310003740 | 1.79 | 82.7 | Disease modification (D) | 2015-12-25 | 2015-12-30 | GemCarbo Days 1+8 | null | N | 310007441 | GEMCARBO |
| 310006572 | 310003741 | 1.81 | 82.4 | Adjuvant (A) | 2013-02-07 | 2013-04-20 | CHOP - 21 days | N | N | 310007443 | CHOP |
| 310006573 | 310009509 | 1.76 | null | Palliative (P) | 2015-08-14 | 2015-08-20 | Bevacizumab 7.5mg/kg | 02 | N | 310007451 | BEVACIZUMAB |
| 310006574 | 310003743 | 1.89 | null | Palliative (P) | 2014-05-16 | 2014-05-27 | Trial Unspecified | 01 | N | 310007451 | TRIAL |
| 310006576 | 310003745 | 1.54 | 59.5 | Adjuvant (A) | 2016-12-05 | 2016-12-07 | Bevacizumab 7.5mg/kg | 02 | N | 310007457 | BEVACIZUMAB |
| 310006578 | 310003749 | 1.8 | 83 | Palliative (P) | 2014-02-06 | 2014-06-03 | Liposomal Doxorubicin (Caelyx) | N | N | 310007466 | LIPOSOMAL DOXORUBICIN |
| 310006579 | 310003750 | 1.72 | 67.7 | Curative (C) | 2013-11-25 | 2013-11-26 | Trial Unspecified | Y | N | 310007467 | TRIAL |
| 310006580 | 310003751 | null | 85.21 | Palliative (P) | 2016-08-24 | 2016-08-27 | Bevacizumab 7.5mg/kg | N | N | 310007468 | BEVACIZUMAB |
| 310006581 | 310003754 | null | 98 | Curative (C) | 2018-01-28 | 2018-01-29 | Liposomal Doxorubicin 40mg/m2 | null | N | 310007474 | LIPOSOMAL DOXORUBICIN |
| 310006582 | 310003754 | null | 63 | Palliative (P) | 2015-05-25 | 2015-05-25 | Trial Unspecified | Y | N | 310007474 | TRIAL |
| 310006583 | 310009514 | 1.52 | 68.9 | Palliative (P) | 2015-04-16 | 2015-09-03 | Bevacizumab 7.5mg/kg | N | N | 310007478 | BEVACIZUMAB |
| 310006584 | 310007532 | 1.49 | 69 | Palliative (P) | 2013-11-17 | 2013-11-19 | Bevacizumab 7.5mg/kg | 02 | N | 310007481 | BEVACIZUMAB |
| 310006585 | 310003758 | 1.48 | 59.9 | Palliative (P) | 2017-09-19 | 2017-09-28 | GEMCARBO | N | N | 310007481 | GEMCARBO |
| 310006586 | 310003758 | 1.63 | 93 | Palliative (P) | 2015-01-09 | 2015-01-20 | Liposomal Doxorubicin (Caelyx) | 2 | null | 310007481 | LIPOSOMAL DOXORUBICIN |
| 310006587 | 310003758 | 1.65 | 64.9 | Curative (C) | 2015-11-06 | 2015-11-07 | Trial Unspecified | null | N | 310007481 | TRIAL |
| 310006588 | 310003759 | 1.66 | 53.6 | null | 2016-10-31 | 2016-12-02 | Trial Unspecified | Y | N | 310007497 | TRIAL |
| 310006589 | 310003759 | 1.57 | 76.3 | Palliative (P) | 2017-09-17 | 2017-09-18 | CARBOPLATIN + GEMCITABINE | N | null | 310007497 | GEMCARBO |